Dr Levy on the Development and Clinical Use of ADCs in NSCLC

Benjamin P. Levy, MD, discusses the current clinical and developmental statuses of several ADCs for patients with non–small cell lung cancer.

Benjamin P. Levy, MD, clinical director, Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital; and associate professor, oncology, Johns Hopkins University School of Medicine, discusses the current clinical and developmental statuses of several antibody-drug conjugates in non–small cell lung cancer.

Related Content:

PER® Winter Lung Cancer ConferenceSidney Kimmel Comprehensive Cancer Center at Johns HopkinsOncLive TVLung CancerConference
Dr Mekhail on a Case Study of Early-Stage, Nonmetastatic Lung Cancer
Shields Spotlights Lessons Learned in Limited-Stage SCLC and Areas Ripe for Further Research
Dr Hales on the Use of Post-Operative Radiotherapy in NSCLC